Skip to Content

Butoconazole topical Side Effects

For the Consumer

Applies to butoconazole topical: intravaginal cream

Side effects include:

Vulvar/vaginal burning, itching, soreness and swelling, pelvic or abdominal pain or cramping.

For Healthcare Professionals

Applies to butoconazole topical: vaginal cream

Genitourinary

Common (1% to 10%): Vulvar/vaginal burning, itching, soreness, swelling; pelvic pain or cramping[Ref]

Local

Frequency not reported: Irritation[Ref]

Gastrointestinal

Common (1% to 10%): Abdominal pain or cramping[Ref]

Nervous system

Frequency not reported: Headache[Ref]

Hematologic

Thrombocytopenia developed 1 week after beginning this drug. It resolved slowly over the next few weeks after drug discontinuation.[Ref]

Frequency not reported: Thrombocytopenia[Ref]

References

1. Brown D Jr, Henzl MR, LePage ME, Tsao LL, Izu AE, Walker KA, Adamson GD, Droegmuller W "Butoconazole vaginal cream in the treatment of vulvovaginal candidiasis. Comparison with miconazole nitrate and placebo." J Reprod Med 31 (1986): 1045-8

2. "Butoconazole or vulvovaginal candidiasis." Med Lett Drugs Ther 28 (1986): 68

3. Ruf H, Vitse M "A comparison of butoconazole nitrate cream with econazole nitrate cream for the treatment of vulvovaginal candidiasis." J Int Med Res 18 (1990): 389-99

4. "Product Information. Femstat (butoconazole)." Syntex Laboratories Inc, Palo Alto, CA.

5. Maloley PA, Nelson E, Montgomery HA, Campbell JR "Severe reversible thrombocytopenia resulting from butoconazole cream." DICP 24 (1990): 143-4

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Some side effects may not be reported. You may report them to the FDA.

Hide